[go: up one dir, main page]

CL2011000262A1 - Virus de bronquitis infecciosa (bi) derivado de un virus similar a qx-bi; composicion de vacuna que comprende dicho virus; procedimiento para preparar dicho virus. - Google Patents

Virus de bronquitis infecciosa (bi) derivado de un virus similar a qx-bi; composicion de vacuna que comprende dicho virus; procedimiento para preparar dicho virus.

Info

Publication number
CL2011000262A1
CL2011000262A1 CL2011000262A CL2011000262A CL2011000262A1 CL 2011000262 A1 CL2011000262 A1 CL 2011000262A1 CL 2011000262 A CL2011000262 A CL 2011000262A CL 2011000262 A CL2011000262 A CL 2011000262A CL 2011000262 A1 CL2011000262 A1 CL 2011000262A1
Authority
CL
Chile
Prior art keywords
virus
prepare
derived
procedure
similar
Prior art date
Application number
CL2011000262A
Other languages
English (en)
Inventor
Geert Jan Boelm
Harmen Geerligs
Cindy Aleida Maria Meinders
Bastiana Geerrtruida Elizabeth Stuurman
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of CL2011000262A1 publication Critical patent/CL2011000262A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/08—Inactivation or attenuation by serial passage of virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20061—Methods of inactivation or attenuation
    • C12N2770/20064—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Virus de bronquitis infecciosa (BI) derivado de un virus similar a QX-BI; composición de vacuna que comprende dicho virus; procedimiento para preparar dicho virus.
CL2011000262A 2008-08-08 2011-02-07 Virus de bronquitis infecciosa (bi) derivado de un virus similar a qx-bi; composicion de vacuna que comprende dicho virus; procedimiento para preparar dicho virus. CL2011000262A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8722808P 2008-08-08 2008-08-08

Publications (1)

Publication Number Publication Date
CL2011000262A1 true CL2011000262A1 (es) 2011-05-06

Family

ID=41211689

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000262A CL2011000262A1 (es) 2008-08-08 2011-02-07 Virus de bronquitis infecciosa (bi) derivado de un virus similar a qx-bi; composicion de vacuna que comprende dicho virus; procedimiento para preparar dicho virus.

Country Status (27)

Country Link
US (1) US9296991B2 (es)
EP (1) EP2331682B1 (es)
JP (3) JP2011530294A (es)
KR (2) KR20110038181A (es)
CN (1) CN102239252B (es)
AR (1) AR072976A1 (es)
AU (1) AU2009279528A1 (es)
BR (1) BRPI0917447A2 (es)
CA (1) CA2732822C (es)
CL (1) CL2011000262A1 (es)
CO (1) CO6351810A2 (es)
CY (1) CY1121567T1 (es)
DK (1) DK2331682T3 (es)
ES (1) ES2702089T3 (es)
HK (1) HK1159164A1 (es)
HU (1) HUE041481T2 (es)
LT (1) LT2331682T (es)
ME (1) ME01270B (es)
MX (1) MX339731B (es)
PL (1) PL2331682T3 (es)
PT (1) PT2331682T (es)
RU (1) RU2568053C2 (es)
SI (1) SI2331682T1 (es)
TR (1) TR201819340T4 (es)
UA (1) UA103330C2 (es)
WO (1) WO2010017440A1 (es)
ZA (1) ZA201100849B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015014271A2 (pt) * 2012-12-18 2017-12-12 Asia Pacific Special Nutrients Sdn Bhd genotipagem de dissociação em alta resolução de ibv, csfv e ndv
CN103028112B (zh) * 2012-12-31 2014-08-06 青岛易邦生物工程有限公司 一种鸡新城疫和传染性支气管炎二联活疫苗
CN103146654B (zh) * 2013-03-25 2014-07-30 浙江诺倍威生物技术有限公司 一株人工弱化的鸡传染性支气管炎病毒及其应用
AU2017274332B2 (en) * 2016-06-02 2024-06-27 Zoetis Services Llc Vaccine against infectious bronchitis
CN108950068B (zh) * 2018-07-18 2021-05-07 浙江大学 一种鸡传染性支气管炎病毒qx型毒株鉴别检测试剂盒
MX2021004907A (es) * 2018-10-31 2021-06-15 Boehringer Ingelheim Vetmedica Gmbh Vacuna de ibv 4/91 con proteina espicular heterologa.
WO2024019579A1 (ko) * 2022-07-22 2024-01-25 주식회사 카브 닭전염성기관지염바이러스 약독화주 및 이를 포함하는 백신조성물
KR102717877B1 (ko) * 2023-06-16 2024-10-16 주식회사 지나이너 외래 qx 유사 바이러스 스파이크 단백질을 포함하는 전염성 기관지염 키메라 바이러스 및 이를 포함하는 백신 조성물
WO2025055902A1 (en) * 2023-09-11 2025-03-20 Boehringer Ingelheim Vetmedica (China) Co., Ltd. Attenuated infectious bronchitis virus and a vaccine comprising the same
CN118546258B (zh) * 2024-06-03 2024-11-29 中国动物卫生与流行病学中心 一种鸡传染性支气管炎病毒抗原表位融合肽及其在间接elisa检测中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5037650A (en) * 1988-03-08 1991-08-06 Akzo N.V. Live combination vaccine
DK0639640T3 (da) * 1993-07-30 2001-01-02 Akzo Nobel Nv Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91
JPH07206705A (ja) * 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
US20010046500A1 (en) 2000-02-29 2001-11-29 Berend Jongsma In ovo protection against infectious bronchitis
EP1610817B1 (en) * 2003-03-03 2009-10-14 Intervet International B.V. Infectious bronchitis virus with an altered spike gene
US7291342B2 (en) 2003-05-19 2007-11-06 Intervet International B.V. Infectious bronchitis virus vaccine

Also Published As

Publication number Publication date
ZA201100849B (en) 2015-10-28
ES2702089T3 (es) 2019-02-27
DK2331682T3 (en) 2018-12-10
US20110305726A1 (en) 2011-12-15
HUE041481T2 (hu) 2019-05-28
KR101732240B1 (ko) 2017-05-02
CO6351810A2 (es) 2011-12-20
EP2331682A1 (en) 2011-06-15
UA103330C2 (ru) 2013-10-10
LT2331682T (lt) 2018-12-10
MX339731B (es) 2016-06-08
PL2331682T3 (pl) 2019-03-29
AR072976A1 (es) 2010-10-06
US9296991B2 (en) 2016-03-29
BRPI0917447A2 (pt) 2015-12-01
ME01270B (me) 2013-06-20
SI2331682T1 (sl) 2019-01-31
JP6397539B2 (ja) 2018-09-26
CA2732822C (en) 2016-09-20
WO2010017440A1 (en) 2010-02-11
RU2011104201A (ru) 2012-08-20
CA2732822A1 (en) 2010-02-11
JP2017212976A (ja) 2017-12-07
TR201819340T4 (tr) 2019-01-21
AU2009279528A1 (en) 2010-02-11
CY1121567T1 (el) 2020-05-29
HK1159164A1 (zh) 2012-07-27
CN102239252B (zh) 2015-04-15
CN102239252A (zh) 2011-11-09
JP2015144605A (ja) 2015-08-13
RU2568053C2 (ru) 2015-11-10
JP2011530294A (ja) 2011-12-22
KR20150020623A (ko) 2015-02-26
MX2011001514A (es) 2011-03-29
EP2331682B1 (en) 2018-10-24
PT2331682T (pt) 2018-12-19
KR20110038181A (ko) 2011-04-13

Similar Documents

Publication Publication Date Title
CL2011000262A1 (es) Virus de bronquitis infecciosa (bi) derivado de un virus similar a qx-bi; composicion de vacuna que comprende dicho virus; procedimiento para preparar dicho virus.
ECSP13012590A (es) Composiciones bioactivas de chromobacterium y metabolitos
CR20150170A (es) Vacunas de inmersión subunidad para peces
CR20120184A (es) Anticuerpos monoclonales frente a progastrina y su usos
CL2010001530A1 (es) Compuestos derivados de tiadiazoliloxifenilamidinas; su procedimiento de preparacion; agentes para combatir microorganismos indeseados que comprende a dichos compuestos; uso; procedimiento para combatir microorganismos indeseados; y compuestos intermediarios.
CR20160206A (es) Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento C5
CL2016002262A1 (es) Composiciones y métodos para modular la expresión de ttr y vhb
MX2010008799A (es) Proceso para estabilizar una composicion de vacuna que contiene adyuvante.
DK2242752T3 (da) Imidazolyl-biphenylimidazoler som hepatitis C-virus-inhibitorer
UY31611A1 (es) Compuestos que comprenden un grupo ciclobutoxi
CL2010001634A1 (es) Compuestos derivados de nucleosidos, inhibidores del virus de la hepatitis c; procedimiento de preparacion; composicion farmaceutica que los comprende; y combinacion farmaceutica.
BRPI0809600A2 (pt) vírus atenuado útil para vacinas
UY34327A (es) ?composiciones y métodos para controlar malezas comprendiendo un polinucleótido y agente de transferencia, y que modulan 4-hidrofenil-piruvato-dioxigenasa?.
DOP2010000328A (es) Inhibidores de bace
EA201591888A1 (ru) Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
EA201490596A1 (ru) Новые производные дигидрохинолин-2-она
WO2008147496A3 (en) Neuraminidase-deficient live influenza vaccines
TR201905272T4 (tr) İmmünojenik bileşim.
CR20130054A (es) Procesos para preparar compuestos antivirales
BR112013016503A2 (pt) composições e método de vacina de vírus da diarreia viral bovina tipo 1b.
BR112015007879A2 (pt) inibidores do vírus da hepatite c
BRPI0912968A2 (pt) turbomáquina, tal como um turborreator de fluxo duplo.
UY31871A (es) Compuestos que comprenden un grupo ciclobutoxi
CL2013000240A1 (es) Formulaciones que comprende un compuesto derivado de ester; compuestos derivados de ester utiles para preparar formulaciones agroquimicas o ecologicas.